First, AD could be a partial consequence of insulin resistance, which affects insulin signaling and favors abnormal deposition of Aβ and phosphorylated Tau accumulation in the brain, leading to cognitive decline (Malkki, 2015). The gene discussed is MAPT; the disease is Alzheimer disease.